H2N2 Flu Design Puzzle Update

Posted by: admin  :  Category: Information

The designed small protein binder against H2 Hemagglutinin results are being analyzed right now and the results are very impressive. We are using the top models as design guides to help us know the differences between binding to H1 and H2 Hemagglutinin. We’ve known for sometime that this design will bind H1 Hemagglutinin (found on the most common strains of the flu and also Spanish flu) but we are trying to extend the design to also bind H2 Hemagglutinin.

Read more…

Share

Health Ranger Show #68: Financial update for Mindful Wealth subscribers

Posted by: admin  :  Category: Facts

Health Ranger Show #65: Interview with Debra Lynn Dadd on toxic chemicals in the homeDebra Lynn Dadd, a top author and expert on toxic chemicals and green living, shares fascinating information on toxic chemicals that may be lurking in your home right now (and what you can use that’s clean and green instead!). Her website is www.DLD123.com
Click here to listen now (MP3).

Read more…

Share

Health Ranger Report #78: Ecuador Update and Moxxor Opportunity

Posted by: admin  :  Category: Facts

Health Ranger Show #74: Interview with Natural Miracles CEO George ZoorobNatural Miracles Inc. CEO George Zoorob talks with the Health Ranger Mike Adams about natural herbal solutions for menstral pain in women.
Click here to listen now (MP3).

Read more…

Share

Coast To Coast AM: Vaccine Update, Optimism, Technology, & The Future 2-02-2011 Download Link

Posted by: admin  :  Category: Vaccine recommendations

Read more…

Share

Flu Vaccine Update

Posted by: admin  :  Category: Vaccine recommendations

Read more…

Share

Alex Isakov Provides H1N1 Update October 23, 2009

Posted by: admin  :  Category: Vaccine recommendations

Read more…

Share

H1N1 vaccine production – H1N1 Update

Posted by: admin  :  Category: H1N1 vaccine production

H1N1 Update

What is in the H1N1 vaccines?
Back in June, when manufacture of the H1N1 vaccine was being discussed, there was some concern that it might contain adjuvants (substances that increase immune response, and may be toxic to some people); or the mercury-based preservative thimoserol, which has been removed from nearly all routine vaccinations for children. The vaccine manufacturers all made the choice to omit adjuvants. There are three forms of vaccine being manufactured—a nasal form, a single dose injection, and a multi-dose vial. Unfortunately there is thimoserol in the multi-dose vials of the H1N1 vaccine. I am recommending the nasal form of the vaccine and the single-dose injection, but because of the thimoserol, I am not recommending vaccination from the multi-dose vials at this time.

Read more…

Share
h1n1 vaccine